Related references
Note: Only part of the references are listed.CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors
Mohit Jain et al.
CHROMOSOME RESEARCH (2021)
miR-21 Plays a Dual Role in Tumor Formation and Cytotoxic Response in Breast Tumors
Tu Dan et al.
CANCERS (2021)
Clinical value of carcinoembryonic antigen in mammary neoplasms of bitches
Igor L. S. Senhorello et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2020)
Circulating microRNA as biomarkers of canine mammary carcinoma in dogs
Eric J. Fish et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2020)
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics
Diana Bautista-Sanchez et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Oesophageal foreign bodies in cats: Clinical and anatomic findings
Naglaa A. Abd Elkader et al.
PLOS ONE (2020)
Expression of blood hepatocyte-derived microRNA-122 in canine multicentric lymphoma with hepatic involvement
Eman S. Ramadan et al.
VETERINARY RESEARCH COMMUNICATIONS (2019)
Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas
Florian Chocteau et al.
FRONTIERS IN VETERINARY SCIENCE (2019)
Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study
Ana Canadas et al.
VETERINARY PATHOLOGY (2019)
Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients
Xuan Li et al.
DISEASE MARKERS (2018)
Evaluation of hepatocyte-derived microRNA-122 for diagnosis of acute and chronic hepatitis of dogs
S. R. Eman et al.
VETERINARY WORLD (2018)
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors
Frederique Nguyen et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer
Chara Papadaki et al.
BREAST CANCER RESEARCH (2018)
Current biomarkers of canine mammary tumors
Ilona Kaszak et al.
ACTA VETERINARIA SCANDINAVICA (2018)
Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases
Roberta Rasotto et al.
VETERINARY PATHOLOGY (2017)
MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer
Yiying Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients
Danian Dai et al.
PLOS ONE (2016)
Incidence of mammary tumors in the canine population living in the Veneto region (Northeastern Italy): Risk factors and similarities to human breast cancer
Marta Vascellari et al.
PREVENTIVE VETERINARY MEDICINE (2016)
Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer
Jianhong Wu et al.
DISEASE MARKERS (2015)
Interplay between microRNAs and WNT/beta-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer
Nastaran Mohammadi Ghahhari et al.
EUROPEAN JOURNAL OF CANCER (2015)
CLINICAL STUDY FOR DIAGNOSIS AND TREATMENT OF CANINE MAMMARY NEOPLASMS (CMNs) USING DIFFERENT MODALITIES
Pankaj Gupta et al.
INDIAN JOURNAL OF ANIMAL RESEARCH (2014)
Determination of carcinoembryonic antigen and cancer antigen (CA 15-3) in bitches with tumours onmammary gland: preliminary report
A. Valencakova-Agyagosova et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2014)
Canine Mammary Tumors: A Review and Consensus of Standard Guidelines on Epithelial and Myoepithelial Phenotype Markers, HER2, and Hormone Receptor Assessment Using Immunohistochemistry
L. Pena et al.
VETERINARY PATHOLOGY (2014)
Expression of vimentin filaments in canine malignant mammary gland tumors: A simulation of clinicopathological features of human breast cancer
Sanaz Rismanchi et al.
BIOMEDICAL REPORTS (2014)
Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer
J. S. Lee et al.
ANNALS OF ONCOLOGY (2013)
Stability of miRNA in human urine supports its biomarker potential
Christine Mall et al.
BIOMARKERS IN MEDICINE (2013)
Retrospective study and immunohistochemical analysis of canine mammary sarcomas
Izabella Dolka et al.
BMC VETERINARY RESEARCH (2013)
miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
Yong Chen et al.
MOLECULAR MEDICINE REPORTS (2013)
Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma
Nazila Nouraee et al.
PLOS ONE (2013)
Prognostic Value of Histological Grading in Noninflammatory Canine Mammary Carcinomas in a Prospective Study With Two-Year Follow-Up: Relationship With Clinical and Histological Characteristics
L. Pena et al.
VETERINARY PATHOLOGY (2013)
CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade
Elisabetta Manuali et al.
BMC VETERINARY RESEARCH (2012)
High expression of miR-210 predicts poor survival in patients with breast cancer: A meta-analysis
Liu Hong et al.
GENE (2012)
CA15.3, CEA and LDH in Dogs with Malignant Mammary Tumors
L. C. Campos et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2012)
Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells
Natasa Anastasov et al.
RADIATION ONCOLOGY (2012)
Canine Mammary Tumours, an Overview
N. Sleeckx et al.
REPRODUCTION IN DOMESTIC ANIMALS (2011)
Development, Anatomy, Histology, Lymphatic Drainage, Clinical Features, and Cell Differentiation Markers of Canine Mammary Gland Neoplasms
K. U. Sorenmo et al.
VETERINARY PATHOLOGY (2011)
Classification and Grading of Canine Mammary Tumors
M. Goldschmidt et al.
VETERINARY PATHOLOGY (2011)
Role of myoepithelial cells in breast tumor progression
Puspa Raj Pandey et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
Cancer antigen 15/3: possible diagnostic use in veterinary clinical oncology. Preliminary study
M. C. Marchesi et al.
VETERINARY RESEARCH COMMUNICATIONS (2010)
Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence(*)
K. U. Sorenmo et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2009)
MicroRNA expression in canine mammary cancer
R. Michelle Boggs et al.
MAMMALIAN GENOME (2008)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)
Shuomin Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
miR-21-mediated tumor growth
M.-L. Si et al.
ONCOGENE (2007)
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Cherie Blenkiron et al.
GENOME BIOLOGY (2007)
Statistical analysis of real-time PCR data
JS Yuan et al.
BMC BIOINFORMATICS (2006)
Histological grading and prognosis in dogs with mammary carcinomas: Application of a human grading method
M Karayannopoulou et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002
A Egenvall et al.
PREVENTIVE VETERINARY MEDICINE (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Mortality in over 350,000 insured Swedish dogs from 1995-2000: I. Breed-, gender-, age- and cause-specific rates
BN Bonnett et al.
ACTA VETERINARIA SCANDINAVICA (2005)
Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis
MG Alexandrakis et al.
RESPIRATORY MEDICINE (2002)
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
FG Ebeling et al.
BRITISH JOURNAL OF CANCER (2002)